Description
If you feel your current approach to cholesterol is “good enough,” but not truly confident or up to date, this diploma is designed for you. You will move from memorising targets to understanding the “why” behind every decision, so your management becomes faster, safer, and more consistent in real clinical practice.What you will be able to do after this diplomaRapidly assess cardiovascular risk and decide who truly needs treatment now vs later, avoiding both over- and under-treatment.Choose and titrate statins and non-statin therapies using current, evidence-based algorithms, instead of guesswork.Handle “difficult” scenarios: statin intolerance, polypharmacy, complex comorbidities, and older or frail patients.Explain risks and benefits to patients in clear language that improves adherence and reduces complaints.Confidently manage secondary prevention in patients with established ASCVD, diabetes, CKD, and familial hypercholesterolaemia.Integrate lifestyle, pharmacology, and follow-up planning into one coherent, repeatable approach for every patient.Who this diploma is forClinicians who worry about “missing something” in lipid results or guideline changes.Doctors, trainees, pharmacists, and allied professionals who want a clear, practical system rather than dense theory.Busy practitioners who want to stop re-reading guidelines before every difficult case.How the course keeps you engagedShort, focused lessons that target one decision at a time, so you always feel a small “win” and clear progress.Realistic clinical cases that force you to think, decide, and then see the evidence behind the answer.Checklists, simple frameworks, and “if/then” patterns you can apply on the ward, in clinic, or in primary care.By the end of this diploma, you will have a structured, evidence-based way to manage cholesterol that you can trust under pressure, even in complex patients. Instead of hoping your decision is correct, you will know exactly why you chose each target, drug, and follow-up plan.





Reviews
There are no reviews yet.